Article
TIAM1 signaling drives prostatic budding and branching phenotypes and is a potential therapeutic target for BPH
2024-02-05
Abstract excerpt
Benign prostatic hyperplasia (BPH) is the most prevalent urologic disease in men aged over 50 years. However, the molecular mechanisms that drive BPH pathophysiology remain elusive. In this study, we integrated bioinformatic and experimental analyses of human BPH to identify TIAM1-RAC1 signaling pathway as a promising candidate for a molecular-based approach for BPH therapy. First, elevated TIAM1 expression in a B...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 45638071-756a-5657-abe3-9a3d03dc89ec
- DOI
- 10.1101/2024.02.02.578055
